These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11193876)
1. Distinctive effects of glicentin, GLP-1 and GLP-2 on adaptive response to massive distal small intestine resection in rats. Hirotani Y; Yamamoto K; Yanaihara C; Balaspiri L; Yanaihara N; Kurokawa K Ann N Y Acad Sci; 2000; 921():460-3. PubMed ID: 11193876 [No Abstract] [Full Text] [Related]
2. Effect of rat glicentin on intestinal adaptation in small intestine-resected rats. Hirotani Y; Taki M; Kataoka K; Kurokawa N; Satoh T; Sasaki K; Yanaihara C; Luo WQ; Yanaihara N Ann N Y Acad Sci; 1998 Dec; 865():601-5. PubMed ID: 9928077 [No Abstract] [Full Text] [Related]
3. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Drucker DJ; Erlich P; Asa SL; Brubaker PL Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7911-6. PubMed ID: 8755576 [TBL] [Abstract][Full Text] [Related]
4. Effect of glucagon, glicentin, glucagon-like peptide-1 and -2 on interdigestive gastroduodenal motility in dogs with a vagally denervated gastric pouch. Shibata C; Naito H; Jin XL; Ueno T; Funayama Y; Fukushima K; Hashimoto A; Matsuno S; Sasaki I Scand J Gastroenterol; 2001 Oct; 36(10):1049-55. PubMed ID: 11589377 [TBL] [Abstract][Full Text] [Related]
5. Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats. Fischer KD; Dhanvantari S; Drucker DJ; Brubaker PL Am J Physiol; 1997 Oct; 273(4):E815-20. PubMed ID: 9357813 [TBL] [Abstract][Full Text] [Related]
6. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Shin ED; Estall JL; Izzo A; Drucker DJ; Brubaker PL Gastroenterology; 2005 May; 128(5):1340-53. PubMed ID: 15887116 [TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 2 is a potent growth factor for small intestine and colon. Litvak DA; Hellmich MR; Evers BM; Banker NA; Townsend CM J Gastrointest Surg; 1998; 2(2):146-50. PubMed ID: 9834410 [TBL] [Abstract][Full Text] [Related]
8. Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine. Pellissier S; Sasaki K; Le-Nguyen D; Bataille D; Jarrousse C Neurogastroenterol Motil; 2004 Aug; 16(4):455-63. PubMed ID: 15306001 [TBL] [Abstract][Full Text] [Related]
9. Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro. Myojo S; Tsujikawa T; Sasaki M; Fujiyama Y; Bamba T J Gastroenterol; 1997 Jun; 32(3):300-5. PubMed ID: 9213241 [TBL] [Abstract][Full Text] [Related]
10. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Brubaker PL; Izzo A; Hill M; Drucker DJ Am J Physiol; 1997 Jun; 272(6 Pt 1):E1050-8. PubMed ID: 9227451 [TBL] [Abstract][Full Text] [Related]
11. Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9-39). Ayachi SE; Borie F; Magous R; Sasaki K; le Nguyen D; Bali JP; Millat B; Jarrousse C Neurogastroenterol Motil; 2005 Apr; 17(2):302-9. PubMed ID: 15787950 [TBL] [Abstract][Full Text] [Related]
12. Effect of glicentin on gut mucosal growth in rats with jejunal and ileal Thiry-Vella fistulas. Hashimoto N; Ohyanagi H; Kazuyuki S J Pediatr Surg; 2003 Apr; 38(4):579-84. PubMed ID: 12677570 [TBL] [Abstract][Full Text] [Related]
13. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats. Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286 [TBL] [Abstract][Full Text] [Related]
14. GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat. Bozkurt A; Näslund E; Holst JJ; Hellström PM Regul Pept; 2002 Jul; 107(1-3):129-35. PubMed ID: 12137975 [TBL] [Abstract][Full Text] [Related]
15. GLP-2 augments the adaptive response to massive intestinal resection in rat. Scott RB; Kirk D; MacNaughton WK; Meddings JB Am J Physiol; 1998 Nov; 275(5):G911-21. PubMed ID: 9815019 [TBL] [Abstract][Full Text] [Related]
16. Intestinal growth in parenterally-fed rats induced by the combined effects of glucagon-like peptide 2 and epidermal growth factor. Kitchen PA; Goodlad RA; FitzGerald AJ; Mandir N; Ghatei MA; Bloom SR; Berlanga-Acosta J; Playford RJ; Forbes A; Walters JR JPEN J Parenter Enteral Nutr; 2005; 29(4):248-54. PubMed ID: 15961680 [TBL] [Abstract][Full Text] [Related]
18. A target cell to oxyntomodulin and glicentin: the antral smooth muscle cell. Rodier G; Magous R; Mochizuki T; Bali JP; Bataille D; Jarrousse C Ann N Y Acad Sci; 1998 Dec; 865():458-62. PubMed ID: 9928049 [No Abstract] [Full Text] [Related]
19. Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2. Drucker DJ; DeForest L; Brubaker PL Am J Physiol; 1997 Dec; 273(6):G1252-62. PubMed ID: 9435550 [TBL] [Abstract][Full Text] [Related]
20. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion. Dhanvantari S; Brubaker PL Endocrinology; 1998 Apr; 139(4):1630-7. PubMed ID: 9528943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]